Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Importance: Gestational diabetes is associated with several poor health outcomes. Objective: To update the 2012 review on screening for gestational diabetes to inform the US Preventive Services Task Force. Data Sources: MEDLINE, EMBASE, and CINAHL (2010 to May 2020), ClinicalTrials.gov, reference lists; surveillance through June 2021. Study Selection: English-language intervention studies for screening and treatment; observational studies on screening; prospective studies on screening test accuracy. Data Extraction and Synthesis: Dual review of titles/abstracts, full-text articles, and study quality. Single-reviewer data abstraction with verification. Random-effects meta-analysis or bivariate analysis (accuracy). Main Outcomes and Measures: Pregnancy, fetal/neonatal, and long-term health outcomes; harms of screening; accuracy. Results: A total of 76 studies were included (18 randomized clinical trials [RCTs] [n = 31 241], 2 nonrandomized intervention studies [n = 190], 56 observational studies [n = 261 678]). Direct evidence on benefits of screening vs no screening was limited to 4 observational studies with inconsistent findings and methodological limitations. Screening was not significantly associated with serious or long-term harm. In 5 RCTs (n = 25 772), 1-step (International Association of Diabetes and Pregnancy Study Group) vs 2-step (Carpenter and Coustan) screening was significantly associated with increased likelihood of gestational diabetes (11.5% vs 4.9%) but no improved health outcomes. At or after 24 weeks of gestation, oral glucose challenge tests with 140- and 135-mg/dL cutoffs had sensitivities of 82% and 93%, respectively, and specificities of 82% and 79%, respectively, against Carpenter and Coustan criteria, and a test with a 140-mg/dL cutoff had sensitivity of 85% and specificity of 81% against the National Diabetes Group Data criteria. Fasting plasma glucose tests with cutoffs of 85 and 90 mg/dL had sensitivities of 88% and 81% and specificities of 73% and 82%, respectively, against Carpenter and Coustan criteria. Based on 8 RCTs and 1 nonrandomized study (n = 3982), treatment was significantly associated with decreased risk of primary cesarean deliveries (relative risk [RR], 0.70 [95% CI, 0.54-0.91]; absolute risk difference [ARD], 5.3%), shoulder dystocia (RR, 0.42 [95% CI, 0.23-0.77]; ARD, 1.3%), macrosomia (RR, 0.53 [95% CI, 0.41-0.68]; ARD, 8.9%), large for gestational age (RR, 0.56 [95% CI, 0.47-0.66]; ARD, 8.4%), birth injuries (odds ratio, 0.33 [95% CI, 0.11-0.99]; ARD, 0.2%), and neonatal intensive care unit admissions (RR, 0.73 [95% CI, 0.53-0.99]; ARD, 2.0%). The association with reduction in preterm deliveries was not significant (RR, 0.75 [95% CI, 0.56-1.01]). Conclusions and Relevance: Direct evidence on screening vs no screening remains limited. One- vs 2-step screening was not significantly associated with improved health outcomes. At or after 24 weeks of gestation, treatment of gestational diabetes was significantly associated with improved health outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Moons, K. G. M., Wolff, R. F., Riley, R. D., Whiting, P. F., Westwood, M., Collins, G. S., Reitsma, J. B., Kleijnen, J., & Mallett, S. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1377 · Cited by 1,669
DeSisto, C. L., Kim, S. Y., & Sharma, A. J. (2014) · Preventing Chronic Disease · doi:10.5888/pcd11.130415 · Cited by 577
Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change
Cornell, J. E., Mulrow, C. D., Localio, R., Stack, C. B., Meibohm, A. R., Guallar, E., & Goodman, S. N. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2886 · Cited by 453
What contributions do languages other than English make on the results of meta-analyses?
Moher, D., Pham, Klassen, T. P., Schulz, K. F., Berlin, J. A., Jadad, A. R., & Liberati, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00188-8 · Cited by 453
Research works printed but not linked: 80
- American College of Obstetricians and Gynecologists, 2018, ACOG Practice Bulletin No. 190 summary: gestational diabetes mellitus., Obstet Gynecol, 131, 406, 10.1097/AOG.0000000000002498 · DOI
- Casagrande, 2018, Prevalence of gestational diabetes and subsequent type 2 diabetes among U.S. women., Diabetes Res Clin Pract, 141, 200, 10.1016/j.diabres.2018.05.010 · DOI · Paper page
- Lavery, 2017, Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010., BJOG, 124, 804, 10.1111/1471-0528.14236 · DOI · Paper page
- Zhou, 2018, Prevalence and trends in gestational diabetes mellitus among women in the US, 2006-2016., Diabetes., 67, 10.2337/db18-121-OR · DOI
- Basri, 2018, The World Health Organization (WHO) versus the International Association of Diabetes and Pregnancy Study Group (IADPSG) diagnostic criteria of gestational diabetes mellitus (GDM) and their associated maternal and neonatal outcomes., Horm Mol Biol Clin Investig, 34
- Khalifeh, 2020, One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial., J Matern Fetal Neonatal Med, 33, 612, 10.1080/14767058.2018.1498480 · DOI
- Scifres, 2015, Gestational diabetes diagnostic methods (GD2M) pilot randomized trial., Matern Child Health J, 19, 1472, 10.1007/s10995-014-1651-4 · DOI
- Sevket, 2014, To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus., J Matern Fetal Neonatal Med, 27, 36, 10.3109/14767058.2013.799656 · DOI · Paper page
- Bevier, 1999, Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia., Am J Perinatol, 16, 269, 10.1055/s-2007-993871 · DOI · Paper page
- Bonomo, 2005, Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial., Diabet Med, 22, 1536, 10.1111/dme.2005.22.issue-11 · doi:10.1111/dme.2005.22.issue-11
- Fadl, 2015, Randomized controlled study in pregnancy on treatment of marked hyperglycemia that is short of overt diabetes., Acta Obstet Gynecol Scand, 94, 1181, 10.1111/aogs.2015.94.issue-11 · doi:10.1111/aogs.2015.94.issue-11
- Hughes, 2018, Prediabetes in pregnancy, can early intervention improve outcomes? a feasibility study for a parallel randomised clinical trial., BMJ Open, 8, 10.1136/bmjopen-2017-018493 · DOI
- Kokanali, 2014, The effect of treatment on pregnancy outcomes in women with one elevated oral glucose tolerance test value., Ginekol Pol, 85, 748
- Osmundson, 2016, Early screening and treatment of women with prediabetes: a randomized controlled trial., Am J Perinatol, 33, 172
- Simmons, 2018, The Treatment Of Booking Gestational Diabetes Mellitus (TOBOGM) pilot randomised controlled trial., BMC Pregnancy Childbirth, 18, 151, 10.1186/s12884-018-1809-y · DOI · Paper page
- Yang, 2014, A randomised translational trial of lifestyle intervention using a 3-tier shared care approach on pregnancy outcomes in Chinese women with gestational diabetes mellitus but without diabetes., J Transl Med, 12, 290, 10.1186/s12967-014-0290-2 · DOI · Paper page
- Deveer, 2013, The effect of diet on pregnancy outcomes among pregnant with abnormal glucose challenge test., Eur Rev Med Pharmacol Sci, 17, 1258
- Vinter, 2018, Lifestyle intervention in Danish obese pregnant women with early gestational diabetes mellitus according to WHO 2013 criteria does not change pregnancy outcomes: results from the LiP (Lifestyle in Pregnancy) study., Diabetes Care, 41, 2079, 10.2337/dc18-0808 · DOI · Paper page
- Chanprapaph, 2004, Prevalence of gestational diabetes mellitus (GDM) in women screened by glucose challenge test (GCT) at Maharaj Nakorn Chiang Mai Hospital., J Med Assoc Thai, 87, 1141
- Hivert, 2012, Impact of the creation of a specialized clinic for prenatal blood sampling and follow-up care in pregnant women., J Obstet Gynaecol Can, 34, 236, 10.1016/S1701-2163(16)35194-5 · DOI
- Solomon, 1996, Variability in diagnostic evaluation and criteria for gestational diabetes., Diabetes Care, 19, 12, 10.2337/diacare.19.1.12 · DOI · Paper page
- Stacey, 2019, Gestational diabetes and the risk of late stillbirth: a case-control study from England, UK., BJOG, 126, 973, 10.1111/1471-0528.15659 · DOI · Paper page
- Daniells, 2003, Gestational diabetes mellitus: is a diagnosis associated with an increase in maternal anxiety and stress in the short and intermediate term?, Diabetes Care, 26, 385, 10.2337/diacare.26.2.385 · DOI
- Doughty, 2018, Barriers to exclusive breastfeeding among women with gestational diabetes mellitus in the United States., J Obstet Gynecol Neonatal Nurs, 47, 301, 10.1016/j.jogn.2018.02.005 · DOI
- Kerbel, 1997, Adverse effects of screening for gestational diabetes: a prospective cohort study in Toronto, Canada., J Med Screen, 4, 128, 10.1177/096914139700400303 · DOI
- Loewenberg Weisband, 2017, Hospital supplementation differentially impacts the association between breastfeeding intention and duration among women with and without gestational diabetes mellitus history., Breastfeed Med, 12, 338, 10.1089/bfm.2017.0019 · DOI
- Oza-Frank, 2017, In-hospital breastfeeding experiences among women with gestational diabetes., Breastfeed Med, 12, 261, 10.1089/bfm.2016.0197 · DOI
- Rumbold, 2002, Women’s experiences of being screened for gestational diabetes mellitus., Aust N Z J Obstet Gynaecol, 42, 131, 10.1111/ajo.2002.42.issue-2 · doi:10.1111/ajo.2002.42.issue-2
- Agarwal, 2006, Gestational diabetes: utility of fasting plasma glucose as a screening test depends on the diagnostic criteria., Diabet Med, 23, 1319, 10.1111/dme.2006.23.issue-12 · doi:10.1111/dme.2006.23.issue-12
- Agarwal, 2000, Fasting plasma glucose as a screening test for gestational diabetes in a multi-ethnic, high-risk population., Diabet Med, 17, 720, 10.1046/j.1464-5491.2000.00371.x · DOI
- Agarwal, 2001, Gestational diabetes screening of a multiethnic, high-risk population using glycated proteins., Diabetes Res Clin Pract, 51, 67, 10.1016/S0168-8227(00)00206-0 · DOI
- Agarwal, 2018, Gestational diabetes mellitus: using the fasting plasma glucose level to simplify the International Association of Diabetes and Pregnancy Study Groups diagnostic algorithm in an adult South Asian population., Can J Diabetes, 42, 500, 10.1016/j.jcjd.2017.12.009 · DOI
- Ayach, 2006, Comparison between 100-g glucose tolerance test and two other screening tests for gestational diabetes: combined fasting glucose with risk factors and 50-g glucose tolerance test., Sao Paulo Med J, 124, 4, 10.1590/S1516-31802006000100002 · DOI
- Benaiges, 2017, Is first-trimester HbA1c useful in the diagnosis of gestational diabetes?, Diabetes Res Clin Pract, 133, 85, 10.1016/j.diabres.2017.08.019 · DOI
- Benhalima, 2018, A modified two-step screening strategy for gestational diabetes mellitus based on the 2013 WHO criteria by combining the glucose challenge test and clinical risk factors., J Clin Med, 7, 13, 10.3390/jcm7100351 · DOI
- Bhavadharini, 2017, Elevated glycated hemoglobin predicts macrosomia among Asian Indian pregnant women (WINGS-9)., Indian J Endocrinol Metab, 21, 184, 10.4103/2230-8210.196003 · DOI
- Braga, 2019, Relationship between inflammatory markers, glycated hemoglobin and placental weight on fetal outcomes in women with gestational diabetes., Arch Endocrinol Metab, 63, 22, 10.20945/2359-3997000000099 · DOI
- Cetin, 1997, Time-dependent gestational diabetes screening values., Int J Gynaecol Obstet, 56, 257, 10.1016/S0020-7292(96)02831-7 · DOI
- Chevalier, 2011, Universal two-step screening strategy for gestational diabetes has weak relevance in French Mediterranean women: should we simplify the screening strategy for gestational diabetes in France?, Diabetes Metab, 37, 419, 10.1016/j.diabet.2011.01.004 · DOI
- Espinosa de los Monteros, 1999, The after breakfast 50-g, 1-hour glucose challenge test in urban Mexican pregnant women: its sensitivity and specificity evaluated by three diagnostic criteria for gestational diabetes mellitus., Acta Obstet Gynecol Scand, 78, 294, 10.1034/j.1600-0412.1999.780404.x · DOI
- Dickson, 2019, Fasting plasma glucose and risk factor assessment: comparing sensitivity and specificity in identifying gestational diabetes in urban black African women., S Afr Med J, 110, 21, 10.7196/SAMJ.2019.v110i1.14089 · DOI
- Göbl, 2012, A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus., Diabetologia, 55, 3173, 10.1007/s00125-012-2726-7 · DOI
- Kauffman, 2006, Detection of gestational diabetes mellitus by homeostatic indices of insulin sensitivity: a preliminary study., Am J Obstet Gynecol, 194, 1576, 10.1016/j.ajog.2006.01.010 · DOI
- Lamar, 1999, Jelly beans as an alternative to a fifty-gram glucose beverage for gestational diabetes screening., Am J Obstet Gynecol, 181, 1154, 10.1016/S0002-9378(99)70099-2 · DOI
- Lekva, 2018, Prediction of gestational diabetes mellitus and pre-diabetes 5 years postpartum using 75-g oral glucose tolerance test at 14-16 weeks’ gestation., Sci Rep, 8, 13392, 10.1038/s41598-018-31614-z · DOI
- Navid, 2014, Glucose challenge test—is it an effective screening tool for gestational diabetes mellitus in low risk population?, RMJ., 39, 428
- Odsæter, 2016, Hemoglobin A1c as screening for gestational diabetes mellitus in Nordic Caucasian women., Diabetol Metab Syndr, 8, 43, 10.1186/s13098-016-0168-y · DOI
- Olagbuji, 2017, Accuracy of 50-g glucose challenge test to detect International Association of Diabetes and Pregnancy Study Groups criteria–defined hyperglycemia., Int J Gynaecol Obstet, 139, 312, 10.1002/ijgo.2017.139.issue-3 · doi:10.1002/ijgo.2017.139.issue-3
- Perea-Carrasco, 2002, A simple index for detection of gestational diabetes mellitus., J R Soc Med, 95, 435, 10.1177/014107680209500903 · doi:10.1177/014107680209500903
- Perucchini, 1999, Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study., BMJ, 319, 812, 10.1136/bmj.319.7213.812 · DOI · Paper page
- Pezeshki, 2019, Early screening of gestational diabetes mellitus using hemoglobin A1c: revising current screening guidelines., Caspian J Intern Med, 10, 16
- Poo, 2019, Optimal first trimester HbA1c threshold to identify Singaporean women at risk of gestational diabetes mellitus and adverse pregnancy outcomes: a pilot study., Obstet Med, 12, 79, 10.1177/1753495X18795984 · DOI
- Poomalar, 2013, A comparison of fasting plasma glucose and glucose challenge test for screening of gestational diabetes mellitus., J Obstet Gynaecol, 33, 447, 10.3109/01443615.2013.771156 · DOI
- Rajput, 2012, Utility of HbA1c for diagnosis of gestational diabetes mellitus., Diabetes Res Clin Pract, 98, 104, 10.1016/j.diabres.2012.02.018 · DOI
- Saadati, 2016, Determination of relationship between HbA1c levels and early diagnosis of gestational diabetes., Int J Pharm Res All Sci., 5, 252
- Sacks, 2003, Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes., Obstet Gynecol, 101, 1197
- Saeedi, 2018, Characteristics of different risk factors and fasting plasma glucose for identifying GDM when using IADPSG criteria: a cross-sectional study., BMC Pregnancy Childbirth, 18, 225, 10.1186/s12884-018-1875-1 · DOI
- Sermer, 1998, The Toronto Tri-Hospital Gestational Diabetes Project: a preliminary review., Diabetes Care, 21, B33
- Sevket, 2014, The use of HbA1c as an aid in the diagnosis of gestational diabetes mellitus., J Obstet Gynaecol, 34, 690, 10.3109/01443615.2014.925855 · DOI
- Sham, 2014, Comparative study of fasting plasma glucose concentration and glucose challenge test for screening gestational diabetes mellitus., JSAFOG., 6, 75, 10.5005/jp-journals-10006-1275 · doi:10.5005/jp-journals-10006-1275
- Sharma, 2018, Predictive value of fasting plasma glucose on first antenatal visit before 20 weeks of gestation to diagnose gestational diabetes mellitus., J Clin Diagn Res., 12, QC01
- Siricharoenthai, 2020, Diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus., J Matern Fet Neonat Med., 33, 3497, 10.1080/14767058.2019.1576169 · DOI
- Soumya, 2015, HbA1c: a useful screening test for gestational diabetes mellitus., Diabetes Technol Ther, 17, 899, 10.1089/dia.2015.0041 · DOI · Paper page
- Trujillo, 2014, Fasting plasma glucose to avoid a full OGTT in the diagnosis of gestational diabetes., Diabetes Res Clin Pract, 105, 322, 10.1016/j.diabres.2014.06.001 · DOI
- Uncu, 1995, The comparison of 50 grams glucose challenge test, HbA1c and fructosamine levels in diagnosis of gestational diabetes mellitus., Clin Exp Obstet Gynecol, 22, 230
- Veres, 2015, The utility of glycated hemoglobin, determined in the second trimester of pregnancy, in diagnosing gestational diabetes., Rom J Diabetes Nutr Metab Dis., 22, 233, 10.1515/rjdnmd-2015-0029 · DOI
- Weerakiet, 2006, Can adiponectin predict gestational diabetes?, Gynecol Endocrinol, 22, 362, 10.1080/09513590600818919 · DOI · Paper page
- Wu, 2018, The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus., Diabetol Metab Syndr, 10, 14, 10.1186/s13098-018-0314-9 · DOI
- Zhu, 2013, Fasting plasma glucose at 24-28 weeks to screen for gestational diabetes mellitus: new evidence from China., Diabetes Care, 36, 2038, 10.2337/dc12-2465 · DOI · Paper page
- Saccone, 2017, One step versus two step approach for gestational diabetes screening: systematic review and meta-analysis of the randomized trials., J Matern Fetal Neonat Med, 1
- Casey, 2015, Does maternal body mass index influence treatment effect in women with mild gestational diabetes?, Am J Perinatol, 32, 93
- Casey, 2020, Effect of treatment of mild gestational diabetes on long-term maternal outcomes., Am J Perinatol, 37, 475, 10.1055/s-0039-1681058 · DOI
- Palatnik, 2015, Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes., Am J Obstet Gynecol, 213, 560.e1, 10.1016/j.ajog.2015.06.022 · DOI · Paper page
- Berggren, 2012, Perinatal outcomes in Hispanic and non-Hispanic white women with mild gestational diabetes., Obstet Gynecol, 120, 1099, 10.1097/AOG.0b013e31827049a5 · DOI
- Lee, 2020, Undiagnosed type 2 diabetes during pregnancy is associated with increased perinatal mortality: a large population-based cohort study in Ontario, Canada., Diabet Med, 37, 1696, 10.1111/dme.14250 · DOI
- Simmons, 2018, Hyperglycaemia in early pregnancy: the Treatment Of Booking Gestational Diabetes Mellitus (TOBOGM) study: a randomised controlled trial., Med J Aust, 209, 405, 10.5694/mja2.2018.209.issue-9 · doi:10.5694/mja2.2018.209.issue-9
- Farrar, 2016, Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis., BMJ, 354, i4694, 10.1136/bmj.i4694 · DOI · Paper page
- Hartling, 2012, Screening and Diagnosing Gestational Diabetes Mellitus. Evid Rep Technol Assess No. 210
- Higgins, 2011, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0
- Wells, 2009, The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analyses.
Cited by
Epidemiology and management of gestational diabetes
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00825-0 · Cited by 431
American College of Obstetricians and Gynecologists (2024) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000005612 · Cited by 46
Pirmatova, D., Dodkhoeva, M., Hasbargen, U., Flemmer, A. W., Abdusamatzoda, Z., Saburova, K., Salieva, N., Radzhabova, S., & Parhofer, K. G. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1869-4159 · Cited by 2
“Interestingly, a recent report by the US Preventive Services Task Force indicates that many aspects of screening for gestational diabetes, remain unclear also in developed countries [24].”
Background
Metadata
- Authors
- Pillay, J., Donovan, L., Guitard, S., Zakher, B., Gates, M., Gates, A., Vandermeer, B., Bougatsos, C., Chou, R., & Hartling, L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-08-10
- Volume
- 326
- Issue
- 6
- Pages
- 539
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3187616180
- Cited by
- 99
- References
- 27
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. https://app.cochat.ai/papers/10.1001/jama.2021.10404
- The paper
- Pillay, J., Donovan, L., Guitard, S., Zakher, B., Gates, M., Gates, A., Vandermeer, B., Bougatsos, C., Chou, R., & Hartling, L. (2021). Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. https://doi.org/10.1001/jama.2021.10404
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.